Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ReFacto AF vs ReFacto in Hemophilia A
NCT00038935Phase 3Completed
- Sponsor
- Pfizer
- Primary completion
- Feb 2003
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of moroctocog alfa in hemophilia A, sponsored by Pfizer. Status: completed.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00038935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038935.